Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
Study in Advanced Solid Tumor Patients
for
Advanced Solid Tumor
Location: Houston TX, San Antonio TX, Nashville TN,
Sponsor: Callio Therapeutics
Sex: All
Age: 18+
Code: NCT07300943
Phase 1, Phase 2, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Location: Conroe TX, The Woodlands TX, Austin TX, San Marcos TX,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Houston TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Houston TX, Pasadena TX, Tomball TX, Lake Charles LA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase 3, Recruiting
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma (HCC)
Location: Houston TX, Orange City FL, Margate FL, Glendale CA,
Sponsor: Shanghai Henlius Biotech
Sex: All
Age: 18 - 65
Code: NCT07176650
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
for
Stroke, Acute
Location: Houston TX, Plano TX, Harlingen TX, El Paso TX,
Sponsor: Santiago Ortega Gutierrez
Sex: All
Age: 18+
Code: NCT06825897
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Galveston TX, Tyler TX, San Antonio TX, Shreveport LA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
for
Hepatopancreaticobiliary (HPB) Malignancy,
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute
Sex: All
Age: 18+
Code: NCT07050771
Phase 2, Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Houston TX, Dallas TX, St Louis MO, Atlanta GA,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
for
Liver Cirrhosis
Location: Houston TX, San Antonio TX, Dallas TX, Arlington TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18 - 70+
Code: NCT07325526
Phase 2, Recruiting
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)